Novavax Inc (NASDAQ:NVAX)

10.56
Delayed Data
As of Jun 29
 -0.59 / -5.33%
Today’s Change
3.92
Today|||52-Week Range
11.45
+78.08%
Year-to-Date

Today’s Trading

Previous close11.16
Today’s open10.61
Day’s range-- - --
Volume4,299,055
Average volume (3 months)3,341,268
Market cap$2.8B
Dividend yield--
Data as of 06/29/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-14.82%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book10.98

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...+0.10+0.47%
KITEKite Pharma Inc-1.49-2.46%
RDUSRadius Health Inc-2.22-3.47%
CTLTCatalent Inc-0.33-1.11%
Data as of 06/29/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers